SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $43,950 | -48.1% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q1 2024 | $84,750 | -96.9% | 15,000 | -97.7% | 0.00% | -95.7% |
| Q4 2023 | $2,752,824 | +76.2% | 641,684 | +42.5% | 0.02% | +64.3% |
| Q3 2023 | $1,562,676 | -19.1% | 450,339 | +8.3% | 0.01% | -17.6% |
| Q2 2023 | $1,932,754 | +3118.0% | 415,646 | +3097.3% | 0.02% | +1600.0% |
| Q1 2023 | $60,060 | -25.7% | 13,000 | +30.0% | 0.00% | 0.0% |
| Q4 2022 | $80,800 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |